The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ovid Therapeutics Inc(NASDAQ:OVID) 
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and ...
Website: http://www.ovidrx.com
Founded: 2014
Full Time Employees: 65
Sector: Healthcare
Industry: Biotechnology
Ovid Therapeutics Days Payable Outstanding ttm (DPO)
Ovid Therapeutics Days Receivable Outstanding ttm (DSO)
Ovid Therapeutics Op Cashflow Per Share ttm
Ovid Therapeutics Free Cashflow Per Share ttm
Ovid Therapeutics Cash Per Share ttm
Ovid Therapeutics P/S ratio ttm
Ovid Therapeutics (GAAP) P/E ratio ttm
Ovid Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.